Joel Greenblatt · Magic Formula: high return on capital at a cheap EV/EBIT
Is TG Therapeutics, Inc. (TGTX) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
64/100
Mixed
2/5 criteria passed
Joel Greenblatt's Criteria, Applied to TGTX
EBIT/EV yield ≥ 10%
key1.9%
ROIC ≥ 25%
key11.1%
EV/EBIT ≤ 12
51.8x
Gross margin ≥ 30%
83.0%
How TGTX Scores on Other Strategies
Live Financial Snapshot
Market cap
$8.89B
P/E (TTM)
12.4x
ROIC (TTM)
11.13%
Gross margin
83.04%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is TGTX's Joel Greenblatt fit score?
TGTX scores 64/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own TGTX?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends TGTX.
How often is this score updated?
TGTX's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends TGTX.
